Free Trial
NASDAQ:HCMA

HCM Acquisition Q1 2026 Earnings Report

HCM Acquisition logo
$10.26 +0.00 (+0.01%)
As of 06/5/2026 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

HCM Acquisition EPS Results

Actual EPS
$0.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

HCM Acquisition Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

HCM Acquisition Announcement Details

Quarter
Q1 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

HCM Acquisition Earnings Headlines

Contrasting UBE (OTCMKTS:UBEOY) & HCM Acquisition (NASDAQ:HCMA)
HCM Acquisition (NASDAQ:HCMA) Trading Up 0.2% - Here's Why
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel
HCM III Acquisition Corp Class A HCMA
Hcm III Acquisition Corp.
See More HCM Acquisition Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like HCM Acquisition? Sign up for Earnings360's daily newsletter to receive timely earnings updates on HCM Acquisition and other key companies, straight to your email.

About HCM Acquisition

HCM Acquisition (NASDAQ:HCMA). is a Delaware‐incorporated special purpose acquisition company (SPAC) that was formed to identify and complete a business combination with one or more target businesses. The company raised capital through its initial public offering and is listed on the Nasdaq under the ticker HCMA. As a blank check vehicle, HCM Acquisition holds its funds in trust until it consummates a qualifying merger, share exchange, asset acquisition or other business combination.

The SPAC is sponsored by affiliates of Healthcare Capital Management LLC, a Los Angeles‐based investment firm with experience in healthcare and life sciences investing. While HCM Acquisition maintains the flexibility to pursue opportunities across a range of sectors—including healthcare, consumer and retail, technology and media—its sponsor’s background provides specialized insight into healthcare and related industries. The management team leverages this expertise, along with an extensive network of industry contacts, to evaluate potential targets and structure transactions aimed at delivering long‐term value for shareholders.

Under the terms of its charter, HCM Acquisition must complete a business combination within the prescribed period, typically 18 to 24 months from its IPO. If no suitable transaction is finalized within this timeframe, the company will liquidate its trust and return funds to public shareholders. At this time, HCM Acquisition continues to explore potential merger candidates and has not yet announced a definitive agreement for a business combination.

View HCM Acquisition Profile